A prospective view of the treatment of adult-onset diabetes with special reference to the University Group Diabetes Program and oral hypoglycemic agents.
D000787:Angina Pectoris / Q000150:complications; D001786:Blood Glucose; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control; D003927:Diet, Diabetic; D005260:Female; D005654:Fundus Oculi; D006029:Glycosuria / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000150:complications; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010629:Phenformin / Q000627:therapeutic use; D010808:Physical Examination; D010919:Placebos; D011446:Prospective Studies; D011507:Proteinuria / Q000150:complications; D014044:Tolbutamide / Q000627:therapeutic use; D014792:Visual Acuity
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D010919:Placebos; D014044:Tolbutamide; D003404:Creatinine; D010629:Phenformin